Nutrigenomics Research Group, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili (URV), Campus Sescelades, Tarragona 43007, Spain.
Technological Unit of Nutrition and Health, EURECAT-Technology Centre of Catalonia, Avinguda Universitat 1, Reus 43204, Spain.
Nutrients. 2017 Sep 22;9(10):1052. doi: 10.3390/nu9101052.
Non-alcoholic fatty liver disease (NAFLD) comprises a wide spectrum of hepatic disorders, from simple steatosis to hepatic necro-inflammation leading to non-alcoholic steatohepatitis (NASH). Although the prevalence of these multifactorial pathologies is continuously increasing in the population, there is still not an established methodology for their treatment other than weight loss and a change in lifestyle habits, such as a hypocaloric diet and physical exercise. In this framework, there is increasing evidence that several food bioactives and dietary patterns are effective for reversing and preventing the onset of these pathologies. Some studies have claimed that better responses are obtained when treatments are performed under a multifaceted approach, using different bioactive compounds that act against complementary targets. Thus, in this work, current strategies for treating NAFLD and NASH based on multi-ingredient-based supplements or the Mediterranean diet, a dietary pattern rich in bioactive compounds, are reviewed. Furthermore, the usefulness of omics techniques to design effective multi-ingredient nutritional interventions and to predict and monitor their response against these disorders is also discussed.
非酒精性脂肪性肝病(NAFLD)包括一系列广泛的肝脏疾病,从单纯性脂肪变性到导致非酒精性脂肪性肝炎(NASH)的肝坏死性炎症。尽管这些多因素病理在人群中的患病率不断增加,但除了减肥和改变生活方式习惯(如低热量饮食和体育锻炼)外,尚无针对它们的既定治疗方法。在这个框架内,越来越多的证据表明,一些食物生物活性物质和饮食模式对于逆转和预防这些疾病的发生是有效的。一些研究声称,当使用针对互补靶点的不同生物活性化合物进行多方面治疗时,会获得更好的反应。因此,在这项工作中,综述了基于多成分补充剂或富含生物活性化合物的地中海饮食的治疗 NAFLD 和 NASH 的当前策略。此外,还讨论了组学技术在设计有效的多成分营养干预措施以及预测和监测其对这些疾病的反应方面的有用性。